232 related articles for article (PubMed ID: 27184577)
1. Di-Peptide-Modified Gemini Surfactants as Gene Delivery Vectors: Exploring the Role of the Alkyl Tail in Their Physicochemical Behavior and Biological Activity.
Al-Dulaymi MA; Chitanda JM; Mohammed-Saeid W; Araghi HY; Verrall RE; Grochulski P; Badea I
AAPS J; 2016 Sep; 18(5):1168-1181. PubMed ID: 27184577
[TBL] [Abstract][Full Text] [Related]
2. Molecular Engineering as an Approach To Modulate Gene Delivery Efficiency of Peptide-Modified Gemini Surfactants.
Al-Dulaymi M; Michel D; Chitanda JM; El-Aneed A; Verrall RE; Grochulski P; Badea I
Bioconjug Chem; 2018 Oct; 29(10):3293-3308. PubMed ID: 30169953
[TBL] [Abstract][Full Text] [Related]
3. Peptide-Modified Gemini Surfactants: Preparation and Characterization for Gene Delivery.
Al-Dulaymi M; Mohammed-Saeid W; El-Aneed A; Badea I
Methods Mol Biol; 2019; 2000():203-225. PubMed ID: 31148017
[TBL] [Abstract][Full Text] [Related]
4. Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.
Mohammed-Saeid W; Michel D; El-Aneed A; Verrall RE; Low NH; Badea I
J Pharm Pharm Sci; 2012; 15(4):548-67. PubMed ID: 23106958
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles.
Singh J; Michel D; Chitanda JM; Verrall RE; Badea I
J Nanobiotechnology; 2012 Feb; 10():7. PubMed ID: 22296763
[TBL] [Abstract][Full Text] [Related]
6. Enhanced gene expression in epithelial cells transfected with amino acid-substituted gemini nanoparticles.
Yang P; Singh J; Wettig S; Foldvari M; Verrall RE; Badea I
Eur J Pharm Biopharm; 2010 Aug; 75(3):311-20. PubMed ID: 20417276
[TBL] [Abstract][Full Text] [Related]
7. Amino acid-substituted gemini surfactant-based nanoparticles as safe and versatile gene delivery agents.
Singh J; Yang P; Michel D; Verrall RE; Foldvari M; Badea I
Curr Drug Deliv; 2011 May; 8(3):299-306. PubMed ID: 21291379
[TBL] [Abstract][Full Text] [Related]
8. Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles.
Wettig SD; Badea I; Donkuru M; Verrall RE; Foldvari M
J Gene Med; 2007 Aug; 9(8):649-58. PubMed ID: 17654656
[TBL] [Abstract][Full Text] [Related]
9. Dicationic Amino Substituted Gemini Surfactants and their Nanoplexes: Improved Synthesis and Characterization of Transfection Efficiency and Corneal Penetration In Vitro.
Narsineni L; Foldvari M
Pharm Res; 2020 Jul; 37(7):144. PubMed ID: 32666411
[TBL] [Abstract][Full Text] [Related]
10. Cellular Uptake and Distribution of Gemini Surfactant Nanoparticles Used as Gene Delivery Agents.
Jin W; Al-Dulaymi M; Badea I; Leary SC; Rehman J; El-Aneed A
AAPS J; 2019 Aug; 21(5):98. PubMed ID: 31388860
[TBL] [Abstract][Full Text] [Related]
11. A flow cytometric approach to study the mechanism of gene delivery to cells by gemini-lipid nanoparticles: an implication for cell membrane nanoporation.
Gharagozloo M; Rafiee A; Chen DW; Foldvari M
J Nanobiotechnology; 2015 Sep; 13():62. PubMed ID: 26415935
[TBL] [Abstract][Full Text] [Related]
12. The Synthesis, Self-Assembled Structures, and Microbicidal Activity of Cationic Gemini Surfactants with Branched Tridecyl Chains.
Pisárčik M; Pupák M; Lukáč M; Devínsky F; Hubčík L; Bukovský M; Horváth B
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801214
[TBL] [Abstract][Full Text] [Related]
13. Structure-delivery relationships of lysine-based gemini surfactants and their lipoplexes.
Damen M; Cristóbal-Lecina E; Sanmartí GC; van Dongen SF; García Rodríguez CL; Dolbnya IP; Nolte RJ; Feiters MC
Soft Matter; 2014 Aug; 10(31):5702-14. PubMed ID: 24969740
[TBL] [Abstract][Full Text] [Related]
14. Mass Spectrometric Detection and Characterization of Metabolites of Gemini Surfactants Used as Gene Delivery Vectors.
Jin W; Purves R; Krol E; Badea I; El-Aneed A
J Am Soc Mass Spectrom; 2020 Feb; 31(2):366-378. PubMed ID: 31922726
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and aggregation properties of dissymmetric phytanyl-gemini surfactants for use as improved DNA transfection vectors.
Wang H; Wettig SD
Phys Chem Chem Phys; 2011 Jan; 13(2):637-42. PubMed ID: 20981388
[TBL] [Abstract][Full Text] [Related]
16. Design and Evaluation of Gemini Surfactant-Based Lipoplexes Modified with Cell-Binding Peptide for Targeted Gene Therapy in Melanoma Model.
Mohammed-Saeid W; Soudy R; Tikoo R; Kaur K; Verrall RE; Badea I
J Pharm Pharm Sci; 2018; 21(1):363-375. PubMed ID: 30266136
[TBL] [Abstract][Full Text] [Related]
17. Sugar-based tertiary amino gemini surfactants with a vesicle-to-micelle transition in the endosomal pH range mediate efficient transfection in vitro.
Fielden ML; Perrin C; Kremer A; Bergsma M; Stuart MC; Camilleri P; Engberts JB
Eur J Biochem; 2001 Mar; 268(5):1269-79. PubMed ID: 11231278
[TBL] [Abstract][Full Text] [Related]
18. The influence of novel gemini surfactants containing cycloalkyl side-chains on the structural phases of DNA in solution.
Pietralik Z; Kumita JR; Dobson CM; Kozak M
Colloids Surf B Biointerfaces; 2015 Jul; 131():83-92. PubMed ID: 25969417
[TBL] [Abstract][Full Text] [Related]
19. The development of simple flow injection analysis tandem mass spectrometric methods for the cutaneous determination of peptide-modified cationic gemini surfactants used as gene delivery vectors.
Al-Dulaymi M; Michel D; Chitanda JM; Badea I; El-Aneed A
J Pharm Biomed Anal; 2018 Sep; 159():536-547. PubMed ID: 30056225
[TBL] [Abstract][Full Text] [Related]
20. Tandem mass spectrometric analysis of novel peptide-modified gemini surfactants used as gene delivery vectors.
Al-Dulaymi M; El-Aneed A
J Mass Spectrom; 2017 Jun; 52(6):353-366. PubMed ID: 28409852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
